Collaboration leverages Alloy’s platform to accelerate the development of innovative oligonucleotide therapeutics- Latest collaboration between the two companies builds on past work together, ...

Third executive appointment of 2026 signals continued investment in AI-driven product security and software supply chain leadership.COLUMBUS, Ohio--(BUSINESS WIRE)--#AI--Finite State, a leader in ...

Differentiated Oral Candidate Targeting Soluble Amyloid Oligomer Pathology, with Additional Mechanism of Action as APOE4 CorrectorALZ-507 IND Program Demonstrated Favorable Nonclinical Safety and ...

POTOMAC, MD / ACCESS Newswire / April 7, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company developing innovative treatments for Alzheimer's ...

MESA, AZ / ACCESS Newswire / April 7, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) ("the Company") today provided an update as its previously announced podcast marketing campaign for Snapshot ...

SHELTON, CT / ACCESS Newswire / April 7, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of ...

WARWICK, GB / ACCESS Newswire / April 7, 2026 / Moolec Science Limited, a wholly owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company"; "Moolec"), an innovation-driven company engineering ...

Continued funding underscores investor confidence and supports advancement of abuse- and overdose-resistant analgesics~ SAN DIEGO, CA / ACCESS Newswire / April 7, 2026 / Ensysce Biosciences, Inc.

NAPLES, FL / ACCESS Newswire / April 7, 2026 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, secures funding for production of $2.5 Million of Inventory to protect ...

Net revenue increase of 5% in Q4 2025 vs. Q3 2025Jaguar received an up-front payment of $16Mof non-dilutive capital in January 2026 upon entering U.S. license agreement with Future Pak for Mytesi® ...